 Immunologic aspects carbamazepine treatment epileptic patients Immune abnormalities epileptic patients antiepileptic drugs AEDs Phenytoin PHT decrease serum IgA IgM levels decrease blastic transformation lymphocytes phytohemoagglutinin PHA effects carbamazepine CBZ immune response effects CBZ immunologic parameters serum concentrations IgA IgG IgM phagocytosis properties polymorphonuclear leukocytes PMNs cytotoxic activity natural killer cells response lymphocytes mitogenic agents Forty healthy individuals epileptic patients carbamazepine CBZ monotherapy age range years study Student test data CBZ effect serum immunoglobulin concentrations lymphocytic reactivity PHA mitogen CBZ significant enhancement phagocytosis properties PMNs increase natural killer NK cell activity negative effect CBZ therapy immune system study